vs

Side-by-side financial comparison of Sphere 3D Corp. (ANY) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

Sphere 3D Corp. is the larger business by last-quarter revenue ($2.7M vs $1.8M, roughly 1.5× INVO Fertility, Inc.). On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs 3.1%). INVO Fertility, Inc. produced more free cash flow last quarter ($-1.8M vs $-23.6M). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs -37.4%).

Sphere 3D Corp is a global technology company specializing in cloud computing, data management, and virtualization solutions. It delivers enterprise-grade products and services tailored for small to medium-sized businesses, large enterprise clients, and public sector entities, focusing on optimizing IT infrastructure efficiency and cutting operational costs for end users.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

ANY vs IVF — Head-to-Head

Bigger by revenue
ANY
ANY
1.5× larger
ANY
$2.7M
$1.8M
IVF
Growing faster (revenue YoY)
IVF
IVF
+19.5% gap
IVF
22.6%
3.1%
ANY
More free cash flow
IVF
IVF
$21.8M more FCF
IVF
$-1.8M
$-23.6M
ANY
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
-37.4%
ANY

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ANY
ANY
IVF
IVF
Revenue
$2.7M
$1.8M
Net Profit
$-2.6M
Gross Margin
Operating Margin
-372.7%
-93.1%
Net Margin
-150.5%
Revenue YoY
3.1%
22.6%
Net Profit YoY
-62.2%
EPS (diluted)
$-6.96
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANY
ANY
IVF
IVF
Q4 25
$2.7M
Q3 25
$2.6M
$1.8M
Q2 25
$3.0M
$1.9M
Q1 25
$2.8M
$1.6M
Q4 24
$2.6M
$1.7M
Q3 24
$2.4M
$1.4M
Q2 24
$4.7M
$1.8M
Q1 24
$6.9M
$1.6M
Net Profit
ANY
ANY
IVF
IVF
Q4 25
Q3 25
$-4.2M
$-2.6M
Q2 25
$1.7M
$-5.3M
Q1 25
$-8.8M
$-17.4M
Q4 24
$-3.6M
Q3 24
$104.0K
$-1.6M
Q2 24
$2.1M
$-2.2M
Q1 24
$-4.5M
$-1.6M
Gross Margin
ANY
ANY
IVF
IVF
Q4 25
Q3 25
25.4%
Q2 25
23.8%
Q1 25
22.1%
35.2%
Q4 24
41.4%
Q3 24
-16.0%
31.0%
Q2 24
15.2%
53.1%
Q1 24
38.0%
45.3%
Operating Margin
ANY
ANY
IVF
IVF
Q4 25
-372.7%
Q3 25
-153.8%
-93.1%
Q2 25
-87.0%
-160.4%
Q1 25
-184.2%
-1042.1%
Q4 24
-328.7%
-202.0%
Q3 24
-218.8%
-90.7%
Q2 24
-122.4%
-100.9%
Q1 24
-26.9%
-95.7%
Net Margin
ANY
ANY
IVF
IVF
Q4 25
Q3 25
-162.0%
-150.5%
Q2 25
55.2%
-283.6%
Q1 25
-311.9%
-1060.1%
Q4 24
-211.3%
Q3 24
4.4%
-113.8%
Q2 24
45.5%
-122.2%
Q1 24
-64.5%
-101.3%
EPS (diluted)
ANY
ANY
IVF
IVF
Q4 25
$-6.96
Q3 25
$-0.15
$-0.77
Q2 25
$0.06
$-13.30
Q1 25
$-0.32
$-12.53
Q4 24
$-4.62
$14.86
Q3 24
$0.01
$-15.11
Q2 24
$0.10
$-22.39
Q1 24
$-0.27
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANY
ANY
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$3.7M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$23.3M
$5.8M
Total Assets
$25.1M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANY
ANY
IVF
IVF
Q4 25
$3.7M
Q3 25
$5.3M
Q2 25
$4.7M
Q1 25
$2.8M
Q4 24
$5.4M
Q3 24
$5.0M
Q2 24
$4.3M
Q1 24
$9.3M
Total Debt
ANY
ANY
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ANY
ANY
IVF
IVF
Q4 25
$23.3M
Q3 25
$29.5M
$5.8M
Q2 25
$32.7M
$2.6M
Q1 25
$30.7M
$3.3M
Q4 24
$39.3M
$12.7M
Q3 24
$35.8M
$-23.3K
Q2 24
$33.4M
$1.4M
Q1 24
$27.5M
$10.2K
Total Assets
ANY
ANY
IVF
IVF
Q4 25
$25.1M
Q3 25
$31.1M
$18.8M
Q2 25
$34.4M
$19.3M
Q1 25
$34.3M
$31.7M
Q4 24
$43.2M
$46.4M
Q3 24
$44.3M
$17.0M
Q2 24
$44.0M
$17.8M
Q1 24
$42.0M
$17.3M
Debt / Equity
ANY
ANY
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANY
ANY
IVF
IVF
Operating Cash FlowLast quarter
$-16.1M
$-1.8M
Free Cash FlowOCF − Capex
$-23.6M
$-1.8M
FCF MarginFCF / Revenue
-867.3%
-101.6%
Capex IntensityCapex / Revenue
275.4%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.5M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANY
ANY
IVF
IVF
Q4 25
$-16.1M
Q3 25
$-3.5M
$-1.8M
Q2 25
$-5.8M
$-1.7M
Q1 25
$-4.1M
$-3.5M
Q4 24
$-4.6M
$-617.4K
Q3 24
$290.0K
$-640.8K
Q2 24
$-3.3M
$-1.5M
Q1 24
$-58.0K
$-260.6K
Free Cash Flow
ANY
ANY
IVF
IVF
Q4 25
$-23.6M
Q3 25
$-5.7M
$-1.8M
Q2 25
$-6.0M
$-1.7M
Q1 25
$-5.1M
$-3.6M
Q4 24
$-13.5M
$-696.3K
Q3 24
$-4.3M
Q2 24
$-1.5M
Q1 24
$-310.3K
FCF Margin
ANY
ANY
IVF
IVF
Q4 25
-867.3%
Q3 25
-218.7%
-101.6%
Q2 25
-200.5%
-92.6%
Q1 25
-181.2%
-216.9%
Q4 24
-511.9%
-40.6%
Q3 24
-184.4%
Q2 24
-82.3%
Q1 24
-19.7%
Capex Intensity
ANY
ANY
IVF
IVF
Q4 25
275.4%
Q3 25
86.5%
0.5%
Q2 25
6.6%
0.5%
Q1 25
36.4%
0.9%
Q4 24
338.7%
4.6%
Q3 24
196.7%
0.0%
Q2 24
0.0%
3.0%
Q1 24
0.0%
3.2%
Cash Conversion
ANY
ANY
IVF
IVF
Q4 25
Q3 25
Q2 25
-3.51×
Q1 25
Q4 24
Q3 24
2.79×
Q2 24
-1.55×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons